How  	How  	 WRB	O
Ebola  	Ebola  	 NNP	B-NP
virus  	virus  	 NN	I-NP
counters  	counters  	 NNS	I-NP
the  	the  	 DT	O
interferon  	interferon  	 JJ	B-NP
system  	system  	 NN	I-NP
Zoonotic  	Zoonotic  	 NNP	I-NP
transmission  	transmission  	 NN	I-NP
of  	of  	 IN	I-NP
Ebola  	Ebola  	 NNP	I-NP
virus  	virus  	 NN	I-NP
( 	( 	 -LRB-	O
EBOV 	EBOV 	 NNP	B-NP
)  	)  	 -RRB-	O
to  	to  	 TO	O
humans  	humans  	 NNS	O
causes  	causes  	 VBZ	O
a  	a  	 DT	O
severe  	severe  	 JJ	O
haemorrhagic  	haemorrhagic  	 JJ	B-NP
fever  	fever  	 NN	I-NP
in  	in  	 IN	O
afflicted  	afflicted  	 JJ	O
individuals  	individuals  	 NNS	O
with  	with  	 IN	O
high  	high  	 JJ	O
case-fatality  	case-fatality  	 JJ	B-NP
rates 	rates 	 NNS	I-NP
.  	.  	 .	O
Neither  	Neither  	 DT	O
vaccines  	vaccines  	 NNS	O
nor  	nor  	 CC	O
therapeutics  	therapeutics  	 NNS	O
are  	are  	 VBP	O
at  	at  	 IN	O
present  	present  	 JJ	O
available  	available  	 JJ	O
to  	to  	 TO	O
combat  	combat  	 VB	O
EBOV  	EBOV  	 JJ	B-NP
infection 	infection 	 NN	I-NP
,  	,  	 ,	O
making  	making  	 VBG	O
the  	the  	 DT	O
virus  	virus  	 NN	O
a  	a  	 DT	O
potential  	potential  	 JJ	B-NP
threat  	threat  	 NN	I-NP
to  	to  	 TO	O
public  	public  	 JJ	B-NP
health 	health 	 NN	I-NP
.  	.  	 .	O
To  	To  	 TO	O
devise  	devise  	 VB	O
antiviral  	antiviral  	 JJ	B-NP
strategies 	strategies 	 NNS	I-NP
,  	,  	 ,	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
important  	important  	 JJ	O
to  	to  	 TO	O
understand  	understand  	 VB	O
which  	which  	 WDT	O
components  	components  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
immune  	immune  	 JJ	O
system  	system  	 NN	O
could  	could  	 MD	O
be  	be  	 VB	O
effective  	effective  	 JJ	O
against  	against  	 IN	O
EBOV  	EBOV  	 NNP	B-NP
infection 	infection 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
interferon  	interferon  	 NN	B-NP
( 	( 	 -LRB-	O
IFN 	IFN 	 NNP	B-NP
)  	)  	 -RRB-	O
system  	system  	 NN	O
constitutes  	constitutes  	 VBZ	O
a  	a  	 DT	O
key  	key  	 JJ	O
innate  	innate  	 JJ	O
defence  	defence  	 NN	O
against  	against  	 IN	O
viral  	viral  	 JJ	B-NP
infections  	infections  	 NNS	I-NP
and  	and  	 CC	O
prevents  	prevents  	 JJ	O
development  	development  	 NN	O
of  	of  	 IN	O
lethal  	lethal  	 JJ	B-NP
disease  	disease  	 NN	I-NP
in  	in  	 IN	O
mice  	mice  	 NNS	O
infected  	infected  	 VBN	O
with  	with  	 IN	O
EBOV  	EBOV  	 NNP	B-NP
strains  	strains  	 NNS	I-NP
not  	not  	 RB	O
adapted  	adapted  	 VBN	O
to  	to  	 TO	O
this  	this  	 DT	O
host 	host 	 NN	O
.  	.  	 .	O
Recent  	Recent  	 JJ	B-NP
research  	research  	 NN	I-NP
revealed  	revealed  	 VBD	O
that  	that  	 DT	O
expression  	expression  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
host  	host  	 NN	B-NP
cell  	cell  	 NN	I-NP
IFN-inducible  	IFN-inducible  	 FW	I-NP
transmembrane  	transmembrane  	 FW	I-NP
proteins  	proteins  	 FW	I-NP
1-3  	1-3  	 FW	O
( 	( 	 -LRB-	O
IFITM1-3 	IFITM1-3 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
tetherin  	tetherin  	 NN	B-NP
is  	is  	 VBZ	O
induced  	induced  	 VBN	O
by  	by  	 IN	O
IFN  	IFN  	 NNP	B-NP
and  	and  	 CC	O
restricts  	restricts  	 VBZ	O
EBOV  	EBOV  	 NNP	B-NP
infection 	infection 	 NN	I-NP
,  	,  	 ,	O
at  	at  	 IN	O
least  	least  	 JJS	O
in  	in  	 IN	O
cell  	cell  	 NN	O
culture  	culture  	 NN	O
model  	model  	 NN	O
systems 	systems 	 NNS	O
.  	.  	 .	O
IFITMs 	IFITMs 	 NNP	B-NP
,  	,  	 ,	O
tetherin  	tetherin  	 NN	B-NP
and  	and  	 CC	O
other  	other  	 JJ	O
effector  	effector  	 JJ	B-NP
molecules  	molecules  	 NNS	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
IFN  	IFN  	 NNP	I-NP
system  	system  	 NN	I-NP
could  	could  	 MD	O
thus  	thus  	 RB	O
pose  	pose  	 VB	O
a  	a  	 DT	O
potent  	potent  	 JJ	O
barrier  	barrier  	 NN	O
against  	against  	 IN	O
EBOV  	EBOV  	 NNP	B-NP
spread  	spread  	 NN	I-NP
in  	in  	 IN	O
humans 	humans 	 NNS	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
EBOV  	EBOV  	 NNP	B-NP
interferes  	interferes  	 VBZ	O
with  	with  	 IN	O
signalling  	signalling  	 JJ	O
events  	events  	 NNS	O
required  	required  	 VBN	O
for  	for  	 IN	O
human  	human  	 JJ	O
cells  	cells  	 NNS	O
to  	to  	 TO	O
express  	express  	 VB	O
these  	these  	 DT	O
proteins 	proteins 	 NNS	O
.  	.  	 .	O
Here 	Here 	 RB	O
,  	,  	 ,	O
we  	we  	 PRP	O
will  	will  	 MD	O
review  	review  	 VB	O
the  	the  	 DT	O
strategies  	strategies  	 NNS	O
employed  	employed  	 VBN	O
by  	by  	 IN	O
EBOV  	EBOV  	 NNP	B-NP
to  	to  	 TO	O
fight  	fight  	 VB	O
the  	the  	 DT	O
IFN  	IFN  	 NNP	B-NP
system 	system 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
we  	we  	 PRP	O
will  	will  	 MD	O
discuss  	discuss  	 VB	O
how  	how  	 WRB	O
IFITM  	IFITM  	 NNP	B-NP
proteins  	proteins  	 NNS	I-NP
and  	and  	 CC	O
tetherin  	tetherin  	 NNS	B-NP
inhibit  	inhibit  	 VBP	O
EBOV  	EBOV  	 JJ	B-NP
infection 	infection 	 NN	I-NP
.  	.  	 .	O
